Easy to Use Solution with PCR Performance1
The Novodiag COVID-19 assay, performed with the Novodiag® System, is a cartridge-based RT-PCR test for qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The test uses nasopharyngeal swab samples from patients.1
Smart Simplicity in On-demand Testing
Dual Targeting1
The assay detects dual targets of SARS-CoV-2 (E and N genes) and report them separately to avoid false negative results due to potential target mutations.
Rapid & Safe Results
The Novodiag rapid ‘sample-in, result-out’ system allows the fully automated detection of novel coronavirus in approximately 1 hour.2 Novodiag's closed system ensures the protection of healthcare professionals from possible contamination.
Cellularity Control
Cellularity control is added to the test to prevent false negative results. Detection of the cellularity control ensures the sample was taken properly and contains sufficient amount of sample material including human epithelial cells.
User-Friendly Science
The user-friendly nature of the Novodiag system means that it can be implemented in decentralised settings as well as high risk and hard to reach areas, without the need for highly trained personnel.
Simplify & Scale the Future of Diagnostics
The Novodiag COVID-19 Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population level screening.
User-friendly Precision Engineering
A simple and fast way to pinpoint patients most at risk with on-demand testing. The small, quiet, stackable, fully-automated system combines easy-to-use functionality with PCR performance, to bring clinical confidence closer to patients.
A Practical Workflow
Step 1
Add sample to cartridge and close with the cap
Step 2
Scan cartridge and sample ID
Step 3
Insert cartridge and start test
Step 4
Fully-automated results and clear reporting, LIS connectivity
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
- Novodiag® COVID-19 Instructions for Use V10-0 – May 2022, Espoo, FINLAND; Mobidiag Ltd. 2022
- Verification Report Novodiag® COVID-19 V4-0
Documents
Safety Data Sheets
Package Inserts
Related Products
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
EC Representative Information wherever applicable